Crestor ads take aim at Vytorin, touting atherosclerosis claim
AstraZeneca is going for the jugular - or rather, the carotid - with new ads emphasizing Crestor's effectiveness at slowing the progression of atherosclerosis.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.